Muscular Dystrophy, Duchenne
"Muscular Dystrophy, Duchenne" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
Descriptor ID |
D020388
|
MeSH Number(s) |
C05.651.534.500.300 C10.668.491.175.500.300 C16.320.322.562 C16.320.577.300
|
Concept/Terms |
Muscular Dystrophy, Duchenne- Muscular Dystrophy, Duchenne
- Cardiomyopathy, Dilated, X-Linked
- Childhood Muscular Dystrophy, Pseudohypertrophic
- Childhood Pseudohypertrophic Muscular Dystrophy
- Duchenne Muscular Dystrophy
- Duchenne-Type Progressive Muscular Dystrophy
- Duchenne Type Progressive Muscular Dystrophy
- Muscular Dystrophy, Childhood, Pseudohypertrophic
- Muscular Dystrophy, Duchenne Type
- Muscular Dystrophy, Pseudohypertrophic
- Pseudohypertrophic Muscular Dystrophy
- Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type
- Muscular Dystrophy, Pseudohypertrophic, Childhood
- Progressive Muscular Dystrophy, Duchenne Type
- Pseudohypertrophic Childhood Muscular Dystrophy
- Pseudohypertrophic Muscular Dystrophy, Childhood
- Cardiomyopathy, Dilated, 3B
Duchenne and Becker Muscular Dystrophy- Duchenne and Becker Muscular Dystrophy
- Muscular Dystrophy, Duchenne and Becker Types
- Duchenne-Becker Muscular Dystrophy
- Duchenne Becker Muscular Dystrophy
- Muscular Dystrophy, Duchenne-Becker
Becker Muscular Dystrophy- Becker Muscular Dystrophy
- Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type
- Muscular Dystrophy, Becker
- Muscular Dystrophy, Becker Type
- Becker's Muscular Dystrophy
- Muscular Dystrophy, Becker's
- Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type
|
Below are MeSH descriptors whose meaning is more general than "Muscular Dystrophy, Duchenne".
- Diseases [C]
- Musculoskeletal Diseases [C05]
- Muscular Diseases [C05.651]
- Muscular Disorders, Atrophic [C05.651.534]
- Muscular Dystrophies [C05.651.534.500]
- Muscular Dystrophy, Duchenne [C05.651.534.500.300]
- Nervous System Diseases [C10]
- Neuromuscular Diseases [C10.668]
- Muscular Diseases [C10.668.491]
- Muscular Disorders, Atrophic [C10.668.491.175]
- Muscular Dystrophies [C10.668.491.175.500]
- Muscular Dystrophy, Duchenne [C10.668.491.175.500.300]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Genetic Diseases, X-Linked [C16.320.322]
- Muscular Dystrophy, Duchenne [C16.320.322.562]
- Muscular Dystrophies [C16.320.577]
- Muscular Dystrophy, Duchenne [C16.320.577.300]
Below are MeSH descriptors whose meaning is more specific than "Muscular Dystrophy, Duchenne".
This graph shows the total number of publications written about "Muscular Dystrophy, Duchenne" by people in this website by year, and whether "Muscular Dystrophy, Duchenne" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 1 | 2 |
2003 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 1 | 2 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 2 | 0 | 2 |
2017 | 2 | 2 | 4 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2023 | 3 | 0 | 3 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscular Dystrophy, Duchenne" by people in Profiles.
-
Distribution of MRI-derived T2 values as a biomarker for in vivo rapid screening of phenotype severity in mdx mice. PLoS One. 2024; 19(9):e0310551.
-
Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions. Health Qual Life Outcomes. 2024 Sep 02; 22(1):72.
-
Cardiac atrial pathology in Duchenne muscular dystrophy. Muscle Nerve. 2024 May; 69(5):572-579.
-
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy. Dis Model Mech. 2024 Jun 01; 17(6).
-
A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET. Int J Mol Sci. 2023 Apr 19; 24(8).
-
Successful treatment of acute myocardial injury of Duchenne muscular dystrophy with steroids: a case report. J Cardiothorac Surg. 2023 Mar 03; 18(1):80.
-
Effects of Glucocorticoids in Murine Models of Duchenne and Limb-Girdle Muscular Dystrophy. Methods Mol Biol. 2023; 2587:467-478.
-
Anti-latent TGFß binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Sci Transl Med. 2021 Sep 08; 13(610):eabf0376.
-
Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. JCI Insight. 2019 12 19; 4(24).
-
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic. J Neuromuscul Dis. 2018; 5(4):407-417.